Latest News

Results from the phase 3 CABINET trial demonstrated a clear progression-free survival benefit with cabozantinib vs placebo in patients with well-differentiated pNET/epNET.
EC Approves Cabozantinib Monotherapy in Previously Treated pNET/epNET

July 25th 2025

Results from the phase 3 CABINET trial demonstrated a clear progression-free survival benefit with cabozantinib vs placebo in patients with well-differentiated pNET/epNET.

Radiotherapy Plus Sintilimab and Chemo Improves pCR in Rectal Cancer
Radiotherapy Plus Sintilimab and Chemo Improves pCR in Rectal Cancer

July 20th 2025

Perioperative Chemo Improves Survival, Control in Esophageal Cancer
Perioperative Chemo Improves Survival, Control in Esophageal Cancer

July 19th 2025

Transarterial chemoembolization plus sorafenib did not significantly improve overall survival in advanced hepatocellular carcinoma vs sorafenib alone.
Transarterial Chemoembolization Regimen Shows PFS Improvement in HCC

July 16th 2025

Phase 1b data show antitumor activity with the givastomig combination across a wide range of CLDN18.2 expression.
Givastomig Regimen Yields Preliminary Activity in Gastric/GEJ Cancers

July 14th 2025

Video Series
Video Interviews
Podcasts
Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.
The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.
Kelley A. Rone, DNP, RN, AGNP-c, provides perspective on approaching end-of-life conversations with patients with GI cancers.
Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.
Jun Gong, MD, and Daneng Li, MD, spoke about trials they feel can impact the gastrointestinal space during a CancerNetwork® X Space.
Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.
Oncology Peer Review On-The-Go: Tanios Bekaii-Saab, MD, and Colleagues Discuss GOZILA Platform for CRC
Oncology Peer Review On-The-Go: Tanios Bekaii-Saab, MD, Talks COLOMATE Platform in CRC With Experts
Oncology Peer Review On-The-Go

More News